Year Year arrow
arrow-active-down-0
Publisher Publisher arrow
arrow-active-down-1
Journal
1
Journal arrow
arrow-active-down-2
Institution Institution arrow
arrow-active-down-3
Institution Country Institution Country arrow
arrow-active-down-4
Publication Type Publication Type arrow
arrow-active-down-5
Field Of Study Field Of Study arrow
arrow-active-down-6
Topics Topics arrow
arrow-active-down-7
Open Access Open Access arrow
arrow-active-down-8
Language Language arrow
arrow-active-down-9
Filter Icon Filter 1
Year Year arrow
arrow-active-down-0
Publisher Publisher arrow
arrow-active-down-1
Journal
1
Journal arrow
arrow-active-down-2
Institution Institution arrow
arrow-active-down-3
Institution Country Institution Country arrow
arrow-active-down-4
Publication Type Publication Type arrow
arrow-active-down-5
Field Of Study Field Of Study arrow
arrow-active-down-6
Topics Topics arrow
arrow-active-down-7
Open Access Open Access arrow
arrow-active-down-8
Language Language arrow
arrow-active-down-9
Filter Icon Filter 1
Export
Sort by: Relevance
  • Supplementary Content
  • 10.11665/j.issn.1000-5048.2023060703
Design, synthesis and biological activity evaluation of water-soluble borneol phosphate prodrug
  • Jun 1, 2024
  • Journal of China Pharmaceutical University
  • Zhang, L + 3 more

  • Supplementary Content
  • 10.11665/j.issn.1000-5048.2023092001
Research progress on the function of ectopic olfactory receptors and their value as drug targets
  • Jun 1, 2024
  • Journal of China Pharmaceutical University
  • Liu, C + 4 more

  • Supplementary Content
  • 10.11665/j.issn.1000-5048.2023030101
Research progress of CAR-T immunotherapy in solid tumors combined with new strategies
  • Aug 1, 2023
  • Journal of China Pharmaceutical University
  • Li, M + 3 more

  • Supplementary Content
  • 10.11665/j.issn.1000-5048.20220603
Research progress of radioprobes targeting fibroblast activating protein
  • Dec 1, 2022
  • Journal of China Pharmaceutical University
  • Lu, Z + 5 more

  • Supplementary Content
  • 10.11665/j.issn.1000-5048.20220613
rhlL23R-CHR/Fc fusion protein inhibits Act-HaCaT inflammation and proliferation by downregulating ENST00000522718
  • Dec 1, 2022
  • Journal of China Pharmaceutical University
  • Wang, L + 5 more

  • Supplementary Content
  • 10.11665/j.issn.1000-5048.20220305
Preparation and characterization of dasatinib albumin micelles
  • Jun 1, 2022
  • Journal of China Pharmaceutical University
  • Wang, W + 3 more

  • Supplementary Content
  • 10.11665/j.issn.1000-5048.20220215
Protective effect and mechanism of Artemisia argyi extract on vancomycin- induced acute kidney injury
  • Apr 1, 2022
  • Journal of China Pharmaceutical University
  • Li, D + 6 more

  • Research Article
  • 10.11665/j.issn.1000-5048.20210101
Progress of research on immune escape mechanism of coronavirus
  • Jan 1, 2021
  • Journal of China Pharmaceutical University
  • R Wang + 5 more

Coronavirus is an important pathogen of humans and animals.Among them, the novel coronavirus disease (COVID-19) breaking out in 2019 has brought a fatal threat to human health.The host's innate immune response is the host's first line of defense against pathogen invasion, but an excessive immune response can also aggravate viral infection and pathological damage.The immune escape of coronavirus is a critical pathogenic mechanism causing death.This work mainly reviews the pathogenic mechanism of coronavirus immune escape from several aspects such as host immunosensor, interferon, cytokine and coronavirus antagonizing host immune response, which provide a theoretical reference for the development of anti-coronavirus drugs.

  • Research Article
  • 10.11665/j.issn.1000-5048.20170516
Intervention effects of the extract of alismatis rhizoma on streptozotocin-induced type 2 diabetic rats
  • Oct 1, 2017
  • Journal of China Pharmaceutical University
  • Lan-Jie Cao + 6 more